NO980976L - Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflater - Google Patents
Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflaterInfo
- Publication number
- NO980976L NO980976L NO980976A NO980976A NO980976L NO 980976 L NO980976 L NO 980976L NO 980976 A NO980976 A NO 980976A NO 980976 A NO980976 A NO 980976A NO 980976 L NO980976 L NO 980976L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- attaching
- substances
- displaying
- materials
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 title 1
- 239000000126 substance Substances 0.000 title 1
- 239000013598 vector Substances 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Adhesive Tapes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
- Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
- Sheet Holders (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9518323.2A GB9518323D0 (en) | 1995-09-07 | 1995-09-07 | Materials and methods relating to the attachment and display of substances on cell surfaces |
PCT/GB1996/002195 WO1997009437A1 (fr) | 1995-09-07 | 1996-09-06 | Materiels et procedes relatifs a la fixation et a la presentation de substances sur des surfaces cellulaires |
Publications (2)
Publication Number | Publication Date |
---|---|
NO980976D0 NO980976D0 (no) | 1998-03-06 |
NO980976L true NO980976L (no) | 1998-05-06 |
Family
ID=10780370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO980976A NO980976L (no) | 1995-09-07 | 1998-03-06 | Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflater |
Country Status (17)
Country | Link |
---|---|
US (1) | US6190662B1 (fr) |
EP (1) | EP0848756B1 (fr) |
JP (1) | JP4180111B2 (fr) |
KR (1) | KR19990044528A (fr) |
CN (1) | CN1201493A (fr) |
AT (1) | ATE270337T1 (fr) |
AU (1) | AU729449B2 (fr) |
BR (1) | BR9610133A (fr) |
CA (1) | CA2231372A1 (fr) |
DE (1) | DE69632827T2 (fr) |
GB (1) | GB9518323D0 (fr) |
HK (1) | HK1014337A1 (fr) |
MX (1) | MX9801864A (fr) |
NO (1) | NO980976L (fr) |
NZ (1) | NZ316580A (fr) |
WO (1) | WO1997009437A1 (fr) |
ZA (1) | ZA967562B (fr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5821088A (en) * | 1990-05-11 | 1998-10-13 | Siga Pharmaceuticals, Inc. | Use of gram-positive bacteria to express recombinant proteins |
GB9521568D0 (en) * | 1995-10-20 | 1995-12-20 | Lynxvale Ltd | Delivery of biologically active polypeptides |
DE19735105A1 (de) * | 1997-08-13 | 1999-03-04 | Univ Albert Ludwigs Freiburg | Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen |
EP0916726A1 (fr) * | 1997-11-13 | 1999-05-19 | Rijksuniversiteit te Groningen | Substances à propriété de fixation sur des microorganismes |
US6100388A (en) * | 1998-03-16 | 2000-08-08 | Biogaia Biologies Ab | Lactobacilli harboring aggregation gene as a vaccine delivery vehicle |
EP1012245A1 (fr) * | 1998-06-25 | 2000-06-28 | Korea Green Cross Corporation | Systeme d'expression de surface de l'antigene de surface et de l'antigene capsidique du virus de l'hepatite b au moyen d'une proteine de nucleation de la glace |
KR100313135B1 (ko) | 1999-02-22 | 2001-11-05 | 윤덕용 | 세포 표면 발현 모체로서의 대장균 유래 세포외막 단백질 c(o |
PT1194554E (pt) | 1999-07-05 | 2007-01-31 | Vlaams Interuniv Inst Biotech | Libertação de péptidos trifólios |
WO2002024883A2 (fr) | 2000-09-25 | 2002-03-28 | Societe Des Produits Nestle S.A. | Bacteries d'acide lactique pouvant reduire la tendance d'un individu a developper des reactions allergiques |
US7060462B2 (en) * | 2000-11-02 | 2006-06-13 | National University Of Singapore | AopB gene, protein,homologs, fragments and variants thereof, and their use for cell surface display |
EP1239032A1 (fr) | 2001-03-02 | 2002-09-11 | Société des Produits Nestlé S.A. | Bactéries lactiques en tant qu'agents pour le traitement et la prévention des allergies |
US7780961B2 (en) * | 2001-05-03 | 2010-08-24 | Actogenix N.V. | Self-containing Lactococcus strain |
DE60319822T2 (de) * | 2002-06-19 | 2009-06-04 | Actogenix Nv | Verfahren und mittel zur erhöhung der darmabsorption |
US7527966B2 (en) * | 2002-06-26 | 2009-05-05 | Transgenrx, Inc. | Gene regulation in transgenic animals using a transposon-based vector |
AU2003286003B2 (en) | 2002-11-08 | 2011-05-26 | Ablynx N.V. | Stabilized single domain antibodies |
WO2004041865A2 (fr) | 2002-11-08 | 2004-05-21 | Ablynx N.V. | Anticorps a domaine unique stabilises |
EP1560935A2 (fr) * | 2002-11-15 | 2005-08-10 | VIB vzw | Souche de lactobacillus autonome |
WO2005012491A2 (fr) * | 2003-01-29 | 2005-02-10 | Osel, Inc. | Expression de surface de proteines biologiquement actives dans des bacteries |
JP4639370B2 (ja) * | 2003-09-17 | 2011-02-23 | ミリポア・コーポレイション | 標的被検体を分析するための組成物および方法 |
WO2006083516A2 (fr) * | 2005-01-12 | 2006-08-10 | Osel, Inc. | Polypeptide de cyanovirine-n modifie |
US8748126B2 (en) | 2005-11-29 | 2014-06-10 | Actogenix N.V. | Induction of mucosal tolerance to antigens |
EP3351268B1 (fr) | 2007-01-25 | 2020-08-05 | Intrexon Actobiotics NV | Traitement d'une maladie immunitaire par l'administration mucosale d'antigènes |
EP1972350A1 (fr) * | 2007-03-20 | 2008-09-24 | Rijksuniversiteit Groningen | Système de double ciblage |
US20110189236A1 (en) * | 2008-05-08 | 2011-08-04 | Emory University | Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria |
CA2738781C (fr) * | 2008-09-29 | 2020-06-09 | Actogenix N.V. | Colonisation reduite de microbes au niveau de la muqueuse |
US9861693B2 (en) | 2012-09-07 | 2018-01-09 | Emory University | HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto |
EP2897638A1 (fr) | 2012-09-24 | 2015-07-29 | Montana State University-Bozeman | Lactococcus lactis recombinant exprimant l'antigène 1 du facteur de colonisation d'escherichia coli (cfa/i) de type pilus et procédés d'utilisation correspondants |
US20240024380A1 (en) * | 2020-12-23 | 2024-01-25 | Chan Zuckerberg Biohub, Inc. | Bacteria-engineered to elicit antigen-specific t cells |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5616686A (en) | 1990-05-11 | 1997-04-01 | The Rockefeller University | Polypeptide of a hybrid surface protein by bacteria |
WO1993018163A2 (fr) * | 1992-03-13 | 1993-09-16 | The Rockefeller University | Apport et expression d'une proteine de surface hybride sur la surface de bacteries gram positif |
US5348867A (en) * | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
-
1995
- 1995-09-07 GB GBGB9518323.2A patent/GB9518323D0/en active Pending
-
1996
- 1996-09-06 ZA ZA9607562A patent/ZA967562B/xx unknown
- 1996-09-06 CN CN96198087A patent/CN1201493A/zh active Pending
- 1996-09-06 WO PCT/GB1996/002195 patent/WO1997009437A1/fr active IP Right Grant
- 1996-09-06 CA CA002231372A patent/CA2231372A1/fr not_active Abandoned
- 1996-09-06 BR BR9610133-4A patent/BR9610133A/pt not_active Application Discontinuation
- 1996-09-06 DE DE69632827T patent/DE69632827T2/de not_active Expired - Lifetime
- 1996-09-06 KR KR1019980701776A patent/KR19990044528A/ko not_active Application Discontinuation
- 1996-09-06 AT AT96929431T patent/ATE270337T1/de not_active IP Right Cessation
- 1996-09-06 AU AU68844/96A patent/AU729449B2/en not_active Ceased
- 1996-09-06 EP EP96929431A patent/EP0848756B1/fr not_active Expired - Lifetime
- 1996-09-06 NZ NZ316580A patent/NZ316580A/en not_active IP Right Cessation
- 1996-09-06 JP JP51098397A patent/JP4180111B2/ja not_active Expired - Fee Related
-
1998
- 1998-03-06 NO NO980976A patent/NO980976L/no unknown
- 1998-03-06 US US09/036,609 patent/US6190662B1/en not_active Expired - Lifetime
- 1998-03-09 MX MX9801864A patent/MX9801864A/es unknown
- 1998-12-24 HK HK98115718A patent/HK1014337A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU6884496A (en) | 1997-03-27 |
ZA967562B (en) | 1998-03-06 |
ATE270337T1 (de) | 2004-07-15 |
NO980976D0 (no) | 1998-03-06 |
EP0848756A1 (fr) | 1998-06-24 |
AU729449B2 (en) | 2001-02-01 |
WO1997009437A1 (fr) | 1997-03-13 |
EP0848756B1 (fr) | 2004-06-30 |
GB9518323D0 (en) | 1995-11-08 |
CA2231372A1 (fr) | 1997-03-13 |
CN1201493A (zh) | 1998-12-09 |
KR19990044528A (ko) | 1999-06-25 |
US6190662B1 (en) | 2001-02-20 |
NZ316580A (en) | 1999-09-29 |
JPH11511983A (ja) | 1999-10-19 |
HK1014337A1 (en) | 1999-09-24 |
JP4180111B2 (ja) | 2008-11-12 |
BR9610133A (pt) | 1999-12-21 |
MX9801864A (es) | 1998-11-29 |
DE69632827D1 (de) | 2004-08-05 |
DE69632827T2 (de) | 2005-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO980976L (no) | Materialer og fremgangsmÕter for Õ feste og fremvise stoffer pÕ celleoverflater | |
FI943389A0 (fi) | Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö | |
ATE286907T1 (de) | Cytokinin-designiertes lerk-5 | |
DE69334100D1 (de) | Elk ligand, ein cytokin | |
ATE353906T1 (de) | Cd27 ligand | |
FI972390A (fi) | Sytokiini nimeltä Lerk-7 | |
DK374087D0 (da) | Fremgangsmaade til fremstilling af proteiner med faktor viii-aktivitet ved hjaelp af mikrobielle voertsceller og ekspressionsvektorer, vaertsceller og antistoffer til anvendelse ved denne | |
ES2072892T3 (es) | Proteina receptora para un factor 2 estimulante de celulas b humanas. | |
BR9508053A (pt) | Construção de DNA vetor de expressão recombinante cepa de levedura e processo para a produção de uma proteina heteróloga | |
MX9204517A (es) | Material esponjoso formado esencialmente por acido hialuronico o sus derivados, y su uso en microcirugia. | |
DK1007537T3 (da) | Receptor-protein med betegnelsen 2F1 | |
NO952039L (no) | Proteiner med glykosyltransferase-aktivitet | |
AU5229498A (en) | Mutants of the lag-3 proteins, products for the expression of these mutants and use | |
DE69130981D1 (de) | Expression von makrophagen-induzierbaren proteinen (mips) in hefezellen | |
DK0434605T3 (da) | Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli | |
NO20000575L (no) | Rekombinant ekspresjon av insulin C-peptid | |
AU7423391A (en) | Dna constructs for the expression of proteins in the mammary gland of transgenetic mammals | |
BR9600270A (pt) | Utilização de arginina processos de extração de uma proteína periplásmica de interesse e de cultura de um microorganismo procarioto transformado com a ajuda de um vetor de expressão | |
BR9101587A (pt) | Processo para obtencao de proteinas de fusao;estrutura de gene;vetor;celula de estreptomiceto;proteina de fusao;e utilizacao da ultima | |
AU7452187A (en) | New human lymphotoxin (TNF-beta) polypeptides their prepartion and use | |
DK0627004T3 (da) | Forbedringer ved eller i forbindelse med malariavaccine | |
DK161487D0 (da) | Alfa-interferon-analoge og fremgangsmaade til fremstilling deraf samt udtrykkelsesvektorer og vaertsorganismer til anvendelse ved fremgangsmaaden. | |
DK400786D0 (da) | Udtrykkelsesvektorer til anvendelse i e.coli | |
WO2000006713A3 (fr) | Techniques et produits de recombinaison relatifs a une expression de proteine | |
NZ237872A (en) | E.coli possessing a mutation in the sno c gene, decreased degradation of recombinant proteins |